Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.
Azadeh Shoaibi, Patricia C. Lloyd, Hui‐Lee Wong, Tainya C. Clarke, Yoganand Chillarige, Rose Do, Mao Hu, Yixin Jiao, Andrew Kwist, Arnstein Lindaas, Kathryn Matuska, Rowan McEvoy, Michelle Ondari, Shruti Parulekar, Xiangyu Shi, Jing Wang, Yun Lu, Joyce Obidi, Cindy Ke Zhou, Jeffrey A. Kelman, Richard A. Forshee, Steven A. Anderson
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Vaccination2019-20 coronavirus outbreakAdverse effectSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVirologyImmunologyPneumoniaOutbreakInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and ThrombosisCOVID-19 Clinical Research Studies